TransMedics Group, Inc. (TMDX) Financials
TMDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 1.4 billion | 940.8 million |
| Dec. 31, 2025 | 1.1 billion | 595.3 million |
| Sept. 30, 2025 | 946.0 million | 590.8 million |
| June 30, 2025 | 890.5 million | 572.4 million |
TMDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -12.1 million | 10.0 million |
| Dec. 31, 2025 | 19.0 million | 9.4 million |
| Sept. 30, 2025 | 61.9 million | 9.1 million |
| June 30, 2025 | 82.5 million | 9.4 million |
TMDX Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 7.3 million |
| Dec. 31, 2025 | 105.4 million |
| Sept. 30, 2025 | 24.3 million |
| June 30, 2025 | 34.9 million |
TMDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 461.7 million | 800.2 million | 350.2 million |
| Dec. 31, 2025 | 488.4 million | 456.4 million | 6.9 million |
| Sept. 30, 2025 | 466.2 million | 506.7 million | 7.7 million |
| June 30, 2025 | 400.6 million | 510.9 million | 7.9 million |
TMDX Shares Outstanding
TMDX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 36.7 million | 24.9 million | 63.0 million | - |
| Dec. 31, 2025 | 15.5 million | 20.7 million | 51.4 million | 1.3 million |
| Sept. 30, 2025 | 7.6 million | 15.3 million | 46.0 million | 1.1 million |
| June 30, 2025 | 9.1 million | 15.9 million | 44.1 million | - |
TMDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 173.9 million | 72.8 million |
| Dec. 31, 2025 | 160.8 million | 67.4 million |
| Sept. 30, 2025 | 143.8 million | 59.2 million |
| June 30, 2025 | 157.4 million | 60.8 million |
TMDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TMDX
Price: $75.48
52 week price:
Earnings Per Share: 4.37 USD
P/E Ratio: 14.71
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 513900
Market Capitalization: 2.4 billion